RosTrace

Tag: BiomarkerDiscovery

Ash Cooper

MicroRNA Revolution: Tiny Molecules, Big Impact on Diagnostics and Precision Medicine

When the first microRNAs (miRNAs) were linked to gene‑silencing more than two decades ago, few foresaw how profoundly these 20–25‑nucleotide regulators would transform life science. Today, miRNAs inform everything from basic cell‑biology experiments to multi‑site clinical trials and point‑of‑care diagnostic devices. In an exclusive interview with News‑Medical, Dr. Lohit Khera—Head of Scientific Sales at Canadian biotech firm Norgen Biotek—explains how advances in RNA extraction, automation, and artificial intelligence (AI) are accelerating the move from discovery to routine clinical deployment.

· 6 min read

Robin Hayes

New Biomarker Predicts Multiple Sclerosis Progression, Offering Hope for Better Treatment Strategies

Researchers at the University of Turku have identified a novel biomarker that may revolutionize how clinicians assess the progression and severity of multiple sclerosis (MS), a chronic autoimmune disease of the central nervous system. The groundbreaking study, published in Nature Medicine, offers promising new directions for both targeted treatment and faster development of therapeutic drugs—particularly for progressive MS, which remains one of the most challenging forms of the disease to treat.

· 3 min read